(Q30981037)

27 June 2017

Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain (English)

1 reference

27 June 2017

1 reference

Johansson A

1

1 reference

27 June 2017

Hubatsch I

2

1 reference

27 June 2017

Akerblom E

3

1 reference

27 June 2017

Lindeberg G

4

1 reference

27 June 2017

Winiwarter S

5

1 reference

27 June 2017

Danielson UH

6

1 reference

27 June 2017

Hallberg A

7

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

27 June 2017

1 reference

27 June 2017

11

1 reference

27 June 2017

2

1 reference

27 June 2017

203-206

1 reference

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

The scientific challenge of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Hepatitis C virus: an overview of current approaches and progress

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Novel approaches to the treatment of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Kinetic and structural analyses of hepatitis C virus polyprotein processing

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Structure of the hepatitis C virus RNA helicase domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Product inhibition of the hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Alpha-ketoamides, alpha-ketoesters and alpha-diketones as HCV NS3 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Peptide-based inhibitors of the hepatitis C virus serine protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900625-9

7 January 2021

10.1016/S0960-894X(00)00625-9

Identifiers

DOI

1 reference

27 June 2017

1 reference